Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
OPERATING MARGIN
0.00%
OPERATING MARGIN AVG TTM
0.00%
OPERATING MARGIN AVG 3Y
0.00%
OPERATING MARGIN AVG 5Y
0.00%
OPERATING MARGIN AVG 10Y
0.00%
OPERATING MARGIN AVG 15Y
0.00%
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 836 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Market Cap
$105.69M
Operating Margin
28.39%
TTM Avg
14.20%
3Y Avg
7.10%
5Y Avg
4.73%
Market Cap
$106.07M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$106.91M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-1578.22%
Market Cap
$107.17M
Operating Margin
-4744.25%
TTM Avg
-2372.13%
3Y Avg
-1186.06%
5Y Avg
-790.71%
Market Cap
$105.67M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$105.02M
Operating Margin
-8.52%
TTM Avg
-145.19%
3Y Avg
-110.33%
5Y Avg
-78.53%
Market Cap
$109.38M
Operating Margin
-6.27%
TTM Avg
-11.63%
3Y Avg
-15.25%
5Y Avg
-16.56%
Market Cap
$104.45M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
-1310.83%
5Y Avg
-1301.48%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Immunic, Inc. (IMUX) | $106.93M | 0.00% | 0.00% | 0.00% | 0.00% |
| Black Diamond Therapeutics, Inc. (BDTX)vs › | $105.69M | 28.39% | 14.20% | 7.10% | 4.73% |
| Vivani Medical, Inc. (VANI)vs › | $106.07M | 0.00% | 0.00% | 0.00% | 0.00% |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP)vs › | $106.91M | 0.00% | 0.00% | 0.00% | -1578.22% |
| Outlook Therapeutics, Inc. (OTLK)vs › | $107.17M | -4744.25% | -2372.13% | -1186.06% | -790.71% |
| Polaryx Therapeutics, Inc. Common Stock (PLYX)vs › | $105.67M | 0.00% | 0.00% | 0.00% | 0.00% |
| Definitive Healthcare Corp. (DH)vs › | $105.02M | -8.52% | -145.19% | -110.33% | -78.53% |
| Cumberland Pharmaceuticals Inc. (CPIX)vs › | $109.38M | -6.27% | -11.63% | -15.25% | -16.56% |
| Anixa Biosciences, Inc. (ANIX)vs › | $104.45M | 0.00% | 0.00% | -1310.83% | -1301.48% |
| OnKure Therapeutics, Inc. (OKUR)vs › | $103.06M | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
0.0%
Operating Margin
0.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
| 2016-12-31 | 0.00% |
| 2016-09-30 | 0.00% |
| 2016-06-30 | 0.00% |
| 2016-03-31 | 0.00% |
| 2015-12-31 | 0.00% |
| 2015-09-30 | 0.00% |
| 2015-06-30 | 0.00% |
| 2015-03-31 | 0.00% |
| 2014-12-31 | 0.00% |
| 2014-09-30 | 0.00% |
| 2014-06-30 | 0.00% |
| 2014-03-31 | 0.00% |
| 2013-12-31 | 0.00% |
| 2013-09-30 | 0.00% |
| 2013-06-30 | 0.00% |
| 2013-03-31 | 0.00% |
| 2012-12-31 | 0.00% |
| 2012-09-30 | 0.00% |
